Actively Recruiting
TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)
Led by University of Colorado, Denver · Updated on 2025-02-28
5000
Participants Needed
4
Research Sites
626 weeks
Total Duration
On this page
Sponsors
U
University of Colorado, Denver
Lead Sponsor
N
Northwestern University Feinberg School of Medicine
Collaborating Sponsor
AI-Summary
What this Trial Is About
A prospective outcomes study in patients with and esophageal cancer (EAC) and Barrett's esophagus (BE) associated neoplasia being evaluated for endoscopic eradication therapy (EET).
CONDITIONS
Official Title
TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with Barrett's related neoplasia and dysplasia
- Patients with esophageal cancer
You will not qualify if you...
- Patients with squamous cell carcinoma
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
UCLA Medical Center
Los Angeles, California, United States, 90095
Actively Recruiting
2
Moffitt Cancer Center
Tampa, Florida, United States, 33612
Actively Recruiting
3
Northwestern Memorial Hospital
Chicago, Illinois, United States, 60611
Actively Recruiting
4
Washington University
St Louis, Missouri, United States, 63130
Actively Recruiting
Research Team
S
Sachin Wani, MD
CONTACT
V
Violette C Simon, MS
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here